Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response

Fig. 1

Prior responders with longer interval length were more likely to respond to anti-EGFR retreatment. Prior responders with longer interval length (longer intervening time between prior anti-EGFR therapy and anti-EGFR retreatment) were more likely to respond to anti-EGFR retreatment by analysis combining prior response to anti-EGFR retreatment and intervening time interval between anti-EGFR treatments: short (< median) or long (≥ median)

Back to article page